iifl-logo-icon 1
IIFL

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

GE Healthcare opens its first 5G Innovation Lab in the country

7 Jul 2022 , 02:07 PM

On Thursday, GE Healthcare announced the opening of its first 5G Innovation Lab outside of the United States in India.

According to the business, 5G has the ability to disrupt the patient care continuum by reshaping diagnosis, therapy, and prognosis. It has the advantage of large capacity, fast data rates, low latency, and very reliable connectivity.

According to a business release, "The 5G Innovation Lab is designed to position GE Healthcare at the forefront of these innovative advancements in patient care, including potentially bringing cutting-edge technology to rural and suburban communities."

The lab will act as a testbed for developing future-ready products and solutions, marking a new frontier in innovation, according to GE Healthcare. It is located in the John F. Welch Technology Centre (JFWTC) Bengaluru, the company's largest R&D facility outside of the United States.

Modern infrastructure is housed there, including a private 5G network for research and development. For academics, the healthcare sector, and entrepreneurs, it offers expertise and a platform for a collaborative ecosystem, promoting research and enabling validation and qualification of 5G-enabled "Precision Healthcare" use cases, according to the statement.

5G in Healthcare is expected to generate revenues of USD 3,667 million by 2026, up from an estimated USD 215 million in 2021. By enabling the swift gathering and transfer of big data files and real-time, high-definition video, which can facilitate quicker analytical insights and streamline clinical decision-making, 5G might play a significant role in revolutionizing the patient experience, according to the business.

According to Jan Makela, President & CEO, Imaging at GE Healthcare, "India is a significant market for us worldwide, and it is absolutely the appropriate time to enter into 5G, which will open a realm of fascinating potential, driving the next wave of growth in Healthcare."

In order to facilitate the interaction of exponential technologies like AI/ML, IoT, Big Data, Edge Computing, and cybersecurity, the GE
Healthcare 5G Innovation Lab will act as a conduit, according to the statement.

Related Tags

  • GE 5G Innovation
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

closeIcon

Get better recommendations & make better investments

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp